Remote hemodynamic guidance before and after left ventricular assist device implantation: short-term results from the HEMO-VAD pilot study.
Future Cardiol
; 17(5): 885-898, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-33410726
ABSTRACT
Aim:
We aimed to assess the safety and feasibility of using CardioMEMS monitoring in patients before and after left ventricular assist device (LVAD) surgery. Patients &methods:
Ten patients accepted for elective LVAD surgery were included, received a CardioMEMS at baseline and were categorized based on mean pulmonary artery pressure (mPAP) ≤25 mmHg (n = 4) or mPAP >25 mmHg [n = 6]) before LVAD surgery.Results:
The combined end point of all-cause mortality, acute kidney injury and/or renal replacement therapy, and right ventricular failure occurred more often in patients with an mPAP >25 mmHg (83 vs 0%, p = 0.017).Conclusion:
This pilot study demonstrates that combining CardioMEMS monitoring with LVAD therapy is safe and generates the hypothesis that patients with an mPAP >25 mmHg before LVAD surgery identify a very high-risk group for adverse clinical outcomes.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Heart-Assist Devices
/
Heart Failure
Type of study:
Guideline
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
Future Cardiol
Journal subject:
CARDIOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Países Bajos